Global Immunomodulators Market by Product (Immunostimulants, Immunosuppressants), Application (HIV, Oncology, Respiratory) - Forecast 2024-2030- Product Image

Sale

Global Immunomodulators Market by Product (Immunostimulants, Immunosuppressants), Application (HIV, Oncology, Respiratory) - Forecast 2024-2030

Report
183 Pages
March 2024
Region: Global
360iResearch™
ID: 5674784

UP TO €846EUR$875USD£727GBP OFF until Dec 31^st 2024

The Immunomodulators Market size was estimated at USD 198.75 billion in 2023, USD 206.46 billion in 2024, and is expected to grow at a CAGR of 3.81% to reach USD 258.26 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Immunomodulators Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Immunomodulators Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Immunomodulators Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., Amgen Inc., Arix Bioscience PLC, Bayer AG, BioNTech SE, Bristol Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Horizon Therapeutics PLC, InDex Pharmaceuticals Holding AB, Johnson & Johnson Services, Inc., Merck & Co., Inc., and Pfizer Inc.

Market Segmentation & Coverage

This research report categorizes the Immunomodulators Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Immunostimulants
  - Antibodies
  - Vaccines
- Immunosuppressants
  - Antibodies
  - Antimetabolites
  - Calcineurin Inhibitors
  - Glucocorticoids
Application
- HIV
- Oncology
- Respiratory

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Immunomodulators Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Immunomodulators Market?
What are the technology trends and regulatory frameworks in the Immunomodulators Market?
What is the market share of the leading vendors in the Immunomodulators Market?
Which modes and strategic moves are suitable for entering the Immunomodulators Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Immunomodulators Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence rate of autoimmune diseases
5.1.1.2. Increasing awareness about inflammatory bowel diseases
5.1.1.3. Presence of strong drug pipeline portfolio
5.1.2. Restraints
5.1.2.1. Adverse effect of immunomodulators drugs and high cost of the products
5.1.3. Opportunities
5.1.3.1. Growing number of clinical studies and R&D activities of immunomodulators
5.1.3.2. Advancement of immunomodulatory therapy for inflammatory bowel disease
5.1.4. Challenges
5.1.4.1. Regulatory policies for the approval of the Immunomodulators medications
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Immunomodulators Market, by Product

6.1. Introduction
6.2. Immunostimulants
6.3.1. Antibodies
6.3.2. Vaccines
6.3. Immunosuppressants
6.4.1. Antibodies
6.4.2. Antimetabolites
6.4.3. Calcineurin Inhibitors
6.4.4. Glucocorticoids

7. Immunomodulators Market, by Application

7.1. Introduction
7.2. HIV
7.3. Oncology
7.4. Respiratory

8. Americas Immunomodulators Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Immunomodulators Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Immunomodulators Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape

11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

12.1. Key Company Profiles
12.1.1. Abbott Laboratories
12.1.2. AbbVie Inc.
12.1.3. Amgen Inc.
12.1.4. Arix Bioscience PLC
12.1.5. Bayer AG
12.1.6. BioNTech SE
12.1.7. Bristol Myers Squibb Company
12.1.8. Eli Lilly and Company
12.1.9. F. Hoffmann-La Roche Ltd.
12.1.10. GlaxoSmithKline PLC
12.1.11. Horizon Therapeutics PLC
12.1.12. InDex Pharmaceuticals Holding AB
12.1.13. Johnson & Johnson Services, Inc.
12.1.14. Merck & Co., Inc.
12.1.15. Pfizer Inc.
12.2. Key Product Portfolio

13. Appendix

13.1. Discussion Guide
13.2. License & Pricing

List of Figures

FIGURE 1. IMMUNOMODULATORS MARKET RESEARCH PROCESS
FIGURE 2. IMMUNOMODULATORS MARKET SIZE, 2023 VS 2030
FIGURE 3. IMMUNOMODULATORS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. IMMUNOMODULATORS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. IMMUNOMODULATORS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. IMMUNOMODULATORS MARKET DYNAMICS
FIGURE 7. IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS IMMUNOMODULATORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS IMMUNOMODULATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES IMMUNOMODULATORS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES IMMUNOMODULATORS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC IMMUNOMODULATORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC IMMUNOMODULATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA IMMUNOMODULATORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA IMMUNOMODULATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. IMMUNOMODULATORS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. IMMUNOMODULATORS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. IMMUNOMODULATORS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. IMMUNOMODULATORS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL IMMUNOMODULATORS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 8. IMMUNOMODULATORS MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. IMMUNOMODULATORS MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 12. IMMUNOMODULATORS MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. IMMUNOMODULATORS MARKET SIZE, BY ANTIMETABOLITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. IMMUNOMODULATORS MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. IMMUNOMODULATORS MARKET SIZE, BY GLUCOCORTICOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 17. IMMUNOMODULATORS MARKET SIZE, BY HIV, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. IMMUNOMODULATORS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. IMMUNOMODULATORS MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS IMMUNOMODULATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. CANADA IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. CANADA IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 35. CANADA IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 36. CANADA IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. MEXICO IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. MEXICO IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 39. MEXICO IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 40. MEXICO IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES IMMUNOMODULATORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC IMMUNOMODULATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. CHINA IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. CHINA IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 57. CHINA IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 58. CHINA IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. INDIA IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. INDIA IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 61. INDIA IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 62. INDIA IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. JAPAN IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. JAPAN IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 69. JAPAN IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 70. JAPAN IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. THAILAND IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. THAILAND IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 93. THAILAND IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 94. THAILAND IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA IMMUNOMODULATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 104. DENMARK IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. DENMARK IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 106. DENMARK IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 107. DENMARK IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. EGYPT IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. EGYPT IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 110. EGYPT IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 111. EGYPT IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. FINLAND IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. FINLAND IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 114. FINLAND IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 115. FINLAND IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. FRANCE IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. FRANCE IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 118. FRANCE IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 119. FRANCE IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. GERMANY IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. GERMANY IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 122. GERMANY IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 123. GERMANY IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. ITALY IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. ITALY IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 130. ITALY IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 131. ITALY IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. NORWAY IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. NORWAY IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 142. NORWAY IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 143. NORWAY IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. POLAND IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. POLAND IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 146. POLAND IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 147. POLAND IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. QATAR IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. QATAR IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 150. QATAR IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 151. QATAR IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. SPAIN IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. SPAIN IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 166. SPAIN IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 167. SPAIN IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. TURKEY IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 177. TURKEY IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 178. TURKEY IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 179. TURKEY IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM IMMUNOMODULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSTIMULANTS, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM IMMUNOMODULATORS MARKET SIZE, BY IMMUNOSUPPRESSANTS, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM IMMUNOMODULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. IMMUNOMODULATORS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 189. IMMUNOMODULATORS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 190. IMMUNOMODULATORS MARKET LICENSE & PRICING

Companies Mentioned

Abbott Laboratories
AbbVie Inc.
Amgen Inc.
Arix Bioscience PLC
Bayer AG
BioNTech SE
Bristol Myers Squibb Company
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline PLC
Horizon Therapeutics PLC
InDex Pharmaceuticals Holding AB
Johnson & Johnson Services, Inc.
Merck & Co., Inc.
Pfizer Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	183
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 206.46 Billion
Forecasted Market Value ( USD ) by 2030	$ 258.26 Billion
Compound Annual Growth Rate	3.8%
Regions Covered	Global
No. of Companies Mentioned	15

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3262EUR$3,374USD£2,802GBP €3624EUR$3,749USD£3,113GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4132EUR$4,274USD£3,549GBP €4591EUR$4,749USD£3,944GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5002EUR$5,174USD£4,297GBP €5558EUR$5,749USD£4,774GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5872EUR$6,074USD£5,044GBP €6525EUR$6,749USD£5,605GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7613EUR$7,874USD£6,539GBP €8458EUR$8,749USD£7,265GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Immunomodulators - Global Strategic Business Report

Immunomodulators Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030

Immunomodulators Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Global Immunomodulators Market Report and Forecast 2023-2031

Global Immunomodulators Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

About the Immunomodulator Market